PatientsVille.com Logo

DYSPEPSIA and Amitriptyline

PatientsVille

DYSPEPSIA Symptoms and Causes

Nearly everyone has had indigestion at one time. It's a feeling of discomfort or a burning feeling in your upper abdomen. You may have heartburn or belch and feel bloated. You may also feel nauseated, or even throw up.

You might get indigestion from eating too much or too fast, eating high-fat foods, or eating when you're stressed. Smoking, drinking too much alcohol, using some medicines, being tired, and having ongoing stress can also cause indigestion or make it worse. Sometimes the cause is a problem with the digestive tract, like an ulcer or GERD.

Avoiding foods and situations that seem to cause it may help. Because indigestion can be a sign of a more serious problem, see your health care provider if it lasts for more than two weeks or if you have severe pain or other symptoms. Your health care provider may use x-rays, lab tests, and an upper endoscopy to diagnose the cause. You may need medicines to treat the symptoms.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for DYSPEPSIA

DYSPEPSIA treatment research studies

Amitriptyline clinical trials, surveys and public health registries


Find Drug Side Effect reports



Amitriptyline Side Effects

Completed Suicide (98)
Toxicity To Various Agents (72)
Overdose (61)
Cardiac Arrest (57)
Somnolence (48)
Pain (47)
Convulsion (45)
Anxiety (44)
Headache (44)
Death (42)
Confusional State (40)
Vomiting (40)
Dizziness (39)
Intentional Overdose (39)
Dyspnoea (38)
Loss Of Consciousness (38)
Nausea (35)
Fatigue (35)
Coma (33)
Respiratory Arrest (33)
Depression (32)
Hypotension (31)
Agitation (31)
Hallucination (29)
Malaise (29)
Fall (28)
Cardio-respiratory Arrest (28)
Syncope (27)
Diarrhoea (26)
Insomnia (26)
Tremor (26)
Pyrexia (25)
Grand Mal Convulsion (25)
Delirium (24)
Asthenia (24)
Abdominal Pain (23)
Feeling Abnormal (23)
Suicide Attempt (23)
Dysarthria (22)
Depressed Level Of Consciousness (21)
Constipation (21)
Deep Vein Thrombosis (21)
Electrocardiogram Qt Prolonged (21)
Serotonin Syndrome (21)
Palpitations (21)
Weight Decreased (20)
Gait Disturbance (20)
Dry Mouth (19)
Metabolic Acidosis (19)
Rash (19)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

im on amitriptyline 25mg,i have my xmas party this weekend and wanted to drink alchol. i wonder is it a good idea

After having been on elavil for 9 years, mostly at 100mg/night, I spent the last 6 months weaning off. Shortly after stopping amitriptyline I now have high blood pressure. Before stopping, and for years before starting, my usual pressure was 115/65,

Be safe !!

Been on amitrip 25mg at night for 8 nights now and have felt and look alot better. although i have diarrihea now and felt abit of nausea here and there . feel a tad tired throughout the day but i think for me the postives outweigh

Can amitriptyline can cause thrombocytopenia ?

Doc gave me 25mg to help me sleep after quitting the weed. not as good as zoplicone though

Does Amtriptyline help tinnitus. I'm taking it at a low dose for jaw problems and fibromyalgia. the 25 mg dose seems to make my tinnitus worse but my pain better. I don't know what to do?

For the past 18 mnths myfifteen year old takes Pizotifen for migraine.Even on low dose it hasvirtually seen off the migraine episodes and apart from initial tiredness for the first few weeks on it, we are not aware of an

Hey i took 500mg of amitriptyline and overdosed and almost Died.. Dont take that much

I have been taken 2 25mg at night for 6 months my mouth is dry all the time i carry water with me everywhere , i have a bloted tummy all the time ! but i die as soon as my head touches the pillow !!i feel fat all the time !!

After i took cetrum i felt dull stomach pain dyspepsia and some gastointestinal problems i stoped it and did not take it next day but i contaniue to have this problem for more than 4 days

At about the third week of 500mg 2x a day, I developed severe dyspepsia ; abdominal pain, gas, and bloating. I also could not eat, had mouth sores, and fatique. I stopped taking the drug. It is now 4 days later, and I still have dyspepsia,

Good Afternoon, i am located in Africa. I have been taking Sompraz to treat dyspepsia. I am pregnant however and i wanted to know if it can have any effect on the unborn child?

My daughter has just been prescriped Atenolol for treating her dyspepsia. When I picked up the prescription at the pharmacy. They had said that they have never heard of Atenolol being used to treat dyspepsia so now Im confused. I have a call into

DYSPEPSIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia
Conditions: Dyspepsia;   Compliance;   Depression
Interventions: Drug: Omeprazole;   Drug: Flupentixol and Melitracen Tablets(for Dyspepsia symptoms) + Omeprazole;   Drug: Flupentixol and Melitracen Tablets(for depression symptoms) + Omeprazole;   Drug: Flupentixol and Melitracen Tablets(without explanation) + Omeprazole
Outcome Measures: compliance of antidepressant medication;   Dyspepsia symptom questionnaire;   psychiatric symptom on Hospital Anxiety and Depression Scale;   quality of life rating;   adverse reaction
2 Unknown  Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia
Conditions: Aspirin;   Dyspepsia
Interventions: Drug: esomeprazole;   Drug: Famotidine
Outcome Measures: Treatment success : The HKDI is less than 16. Treatment was considered to have failed if a patient had taken medication for Dyspepsia (other than antacids) during the study period;   Treatment success: no significant Dyspepsia defined by the Global Dyspepsia Score
3 Unknown  Effect Of Itopride On Gastric Emptying And Accommodation In Patients With Functional Dyspepsia
Conditions: Functional Dyspepsia;   Gastric Emptying;   Gastric Accommodation
Interventions: Drug: Itopride,;   Drug: Placebo
Outcome Measures: To assess the effect of Itopride on Gastric Emptying,accommodation and capacity of tolerating a nutrient drink in patients with Functional Dyspepsia;   To assess the effect of Itopride on symptom improvement in patient with Functional Dyspepsia
4 Recruiting Acupuncture for Patients With Function Dyspepsia
Conditions: Functional Dyspepsia;   Postprandial Distress Syndrome
Interventions: Other: acupuncture;   Other: sham acupuncture
Outcome Measures: The proportion of participants reporting complete absence of dyspeptic symptoms;   validated Leeds Dyspepsia Questionnaire;   Nepean Dyspepsia index;   adverse events in each group
5 Unknown  Corticotropin Releasing Hormone (CRH) Responsiveness in Children With Functional Dyspepsia
Condition: Functional Dyspepsia
Intervention: Drug: Acthrel
Outcome Measures: Heart rate variability;   Stress profile;   plasma protein levels;   BASC 2 profile;   STICSA-C;   GI symptom severity scale
6 Recruiting Ghrelin and Gastric Emptying in Children With Functional Dyspepsia
Condition: Functional Dyspepsia
Intervention:
Outcome Measures: Children with FD: exploration of relationships between ghrelin concentration, liquid gastric emptying, and Dyspepsia subtype;   Children with FD: SUBJECTIVE SYMPTOM SEVERITY and correlations between plasma ghrelin concentrations (acyl and desacyl) and gastric emptying.
7 Unknown  Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition
Condition: Functional Dyspepsia
Interventions: Drug: Gabapentin;   Drug: Placebo
Outcome Measures: The primary outcome will be the adequacy of symptom control during the last week of the study.;   Secondary outcomes equate Dyspepsia symptoms with quality of life. The Nepean Dyspepsia Index scores patients on five categories while the Global Overall Symptom Scale measures the severity of Dyspepsia on a 1-7 scale.
8 Unknown  Mirtazapine Versus Placebo in Functional Dyspepsia
Condition: Functional Dyspepsia
Intervention: Drug: Mirtazapine
Outcome Measures: Difference in Dyspepsia symptom scores week 8 versus week 0;   Individual symptom severities;   Nepean Dyspepsia index for quality of life in functional Dyspepsia
9 Not yet recruiting Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia
Condition: Dyspepsia
Interventions: Drug: Rebamipide;   Drug: Placebo (for Esomeprazole);   Drug: Esomeprazole
Outcome Measures: Dyspepsia symptoms;   quality of life
10 Recruiting Effect of Acupuncture on Patients With Functional Dyspepsia: a Multi-center, Randomized, Waitlist-controlled Trial
Condition: Functional Dyspepsia
Intervention: Device: Acupuncture
Outcome Measures: Proportion of responders;   Nepean Dyspepsia Index - Korean version (NDI-K);   EuroQol-5 Dimension (EQ-5D);   Functional Dyspepsia-Related Quality of Life (FD-QoL) Questionnaire;   Beck's Depression Inventory (BDI);   The State-Trait Anxiety Inventory (STAI);   Ghrelin hormone measurement (1. Total ghrelin, 2. Deacylated ghrelin);   Genotype analysis by Axiom® exome genotyping arrays
11 Unknown  Functional Dyspepsia - Effect of Acid-Reducing Treatment and Information on Various Types of Dysmotility
Condition: Dyspepsia
Interventions: Procedure: Individualized and comprehensive information;   Drug: Lanzo Melt
Outcome Measure: Improvement of symptom score
12 Recruiting BRAVO Study for Functional Dyspepsia
Conditions: Dyspepsia;   Gastroesophageal Reflux
Interventions: Drug: Esomeprazole 20mg;   Other: Placebo
Outcome Measures: The primary outcome measure is the proportion of patients who report positive response to adequate relief of dyspeptic symptoms at week 8.;   The secondary outcome measures include dyspeptic symptom scores, symptom association probability of dyspeptic symptoms in relation to esophageal pH of less than 4 as measured at 1 cm above SCJ.
13 Recruiting SSRI Study for Functional Dyspepsia (SS)
Conditions: Dyspepsia;   Anxiety;   Depression
Interventions: Drug: Escitalopram;   Other: Placebo
Outcome Measures: To evaluate the change of serotonin and ghrelin level in blood plasma before and after treatment;   To measure expression of serotonin and ghrelin blood plasma, the rate of adequate relief using global symptom assessment, symptom scores and the fullness rating of the Fullness Rating Scale (FRS) during satiety test
14 Unknown  Mucosal Barrier Defects in Functional Dyspepsia by Confocal Laser Endomicroscopy
Condition: Functional Dyspepsia
Intervention:
Outcome Measures: Specific microscopic changes in the gastric mucosa as seen under the confocal endomicroscope;   the relationship among minimal changes, FD symptoms , neuropeptides and immune responses.
15 Recruiting Comparison of Pantoprazole and Ranitidine in Dyspepsia
Condition: Dyspepsia
Interventions: Drug: Pantoprazole;   Drug: Ranitidine
Outcome Measures: Visual analogue scale score;   Need for additional drug
16 Unknown  Safety Study of a Chinese Herbal Formula Simotang Oral Liquid for the Treatment of Functional Dyspepsia
Conditions: Functional Dyspepsia(FD) Was Studied;   Effect of Simotang on FD Was Studied
Intervention:
Outcome Measures: Improvement of gastrointestinal Symptom as efficacy and the Number of Participants with Adverse Events as a Measure of Safety;   Chinese version of the Nepean Dyspepsia Index as a Measure of efficacy
17 Unknown  The Efficacy of Pantoprazole Treatment in Patients With Functional Dyspepsia
Condition: Nonulcer Dyspepsia
Interventions: Drug: Pantoprazol;   Drug: Folic Acid
Outcome Measure: Effectiveness of pantoprazole treatment in patients with functional Dyspepsia measured by symptoms scale.
18 Not yet recruiting The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia
Condition: Functional Dyspepsia
Interventions: Drug: Rikkunshito;   Drug: Rikkunshito placebo
Outcome Measures: Global assessment of overall treatment efficacy (OTE);   Global overall symptom (GOS)
19 Unknown  Does Visceral Manipulation Works in Treating Functional Dyspepsia?
Condition: Functional Dyspepsia
Interventions: Procedure: Visceral Manipulation;   Drug: PPIs and/or Domperidone
Outcome Measure: FD symptoms: Bothersome postprandial fullness
 / Early satiation / Epigastric pain / Epigastric burning
20 Recruiting Rifaximin for Functional Dyspepsia
Condition: Functional Dyspepsia
Interventions: Drug: Rifaximin;   Drug: Placebo
Outcome Measures: Adequate relief of dyspeptic symptoms at end of treatment;   Individual dyspeptic symptom scores